| Old Articles: <Older 8111-8120 Newer> |
|---|
 |
The Motley Fool
December 7, 2011
Shubh Datta |
Should You Worry About Medco's Debt? A look at Medco Health's debt situation.   |
The Motley Fool
December 7, 2011
Brian Orelli |
As the Biotech Saying Goes... Another delay for Protalix BioTherapeutics makes you think. |
The Motley Fool
December 7, 2011
Dan Caplinger |
Has PDL BioPharma Become the Perfect Stock? Having moved from special dividends to a pure regular-dividend payout has improved income visibility for shareholders. |
The Motley Fool
December 6, 2011
Evan Niu |
iPad: Just What the Doctor Ordered The iPad shows promising potential in the medical market. |
The Motley Fool
December 6, 2011
Brian Orelli |
Pfizer Faces Firing Line A panel of outside experts will help decide Inlyta's fate. |
The Motley Fool
December 6, 2011
Stephanie Baum |
Senators Question Pfizer Lipitor Deals, Ranbaxy Gets FDA Approval for Generic Version Some senators are concerned that Pfizer's deals with pharmacy benefit managers will undermine the sale of generic versions of Lipitor. |
The Motley Fool
December 5, 2011
Brian Orelli |
Up 20%, but Uncertainty Still Looms Affymax is still a risky bet. |
The Motley Fool
December 5, 2011
Travis Hoium |
Health Management Associates Shares Jumped: What You Need to Know Shares of Health Management Associates jumped 11% today as analysts told clients last week's sell-off was overdone. |
The Motley Fool
December 5, 2011
Alexander Crawford |
Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies Do you think these companies will contribute to a cure? |
The Motley Fool
December 2, 2011
Anders Bylund |
Idenix Pharmaceuticals Shares Surged: What You Need to Know Shares of biotech firm Idenix Pharmaceuticals jumped as much as 11.9% on higher-than-average trading volume. |
| <Older 8111-8120 Newer> Return to current articles. |
